Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation

NCT02495662 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT02495662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02495662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation
Lead sponsor
Leiden University Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2015
Completion date
May 30, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamics, neointima, renal dialysis, vascular remodeling